Skip Navigation
Earth Day Imaging Competition submission of Non-Small Cell Lung Cancer Tissue captured using SPECTRA X Light Engine. 6-plex biomarker profiling of Oral Cavity Tumor tissue (CD3, CD68, CD11c, CD20, Ki67 and Cytokeratin). Nuclear Counterstain shown in blue.
(opens in new window)
Earth Day Imaging Competition submission of Non-Small Cell Lung Cancer Tissue captured using SPECTRA X Light Engine. 6-plex biomarker profiling of Oral Cavity Tumor tissue (CD3, CD68, CD11c, CD20, Ki67 and Cytokeratin). Nuclear Counterstain shown in blue.
(opens in new window)
(opens in new window)
Acquired using a SOLA SE Light Engine.
TissueGnostics GmbH (Austria), images were acquired with TissueFAXS CHROMA – multispectral tissue cytometer
(opens in new window)
Human stem cell-derived retinal ganglion cells, 
triple immunostained for differentiation markers 
MAP2 (yellow), Tuj1 magenta) and Brn3a (cyan). 
Acquired using a CELESTA light engine coupled 
to a CrestOptics X-Light V3 spinning disk 
confocal scanner on a Nikon Ti2 microscope with 
a 40X/1.25 NA water objective.
(opens in new window)
Human stem cell-derived retinal ganglion cells, triple immunostained for differentiation markers MAP2 (yellow), Tuj1 magenta) and Brn3a (cyan). Acquired using a CELESTA light engine coupled to a CrestOptics X-Light V3 spinning disk confocal scanner on a Nikon Ti2 microscope with a 40X/1.25 NA water objective.
Silvia Di Angelantonio, Alessandro Soloperto and Maria Giubettini, Center for Life Nano Science, Italian Institute of Technology, Rome in collaboration with CrestOptics S.p.A
(opens in new window)
CPU socket. Modern technology. Big data center. Mobile device. Light effect. Future microcontroller. Blockchain. Energy grid Super system. Virtual reality. Digital signal. Overclock module
(opens in new window)
Semiconductor Wafer
(opens in new window)

Smarter Alternatives with Mercury-Free Lighting.

"Lumencor Light Engines turn on and off instantaneously, require no bulb exchange, and have a small footprint. All of which are important at our core facility environment."

Pawel Pasierbeck Ph.D., The Research Institute of Molecular Pathology, Austria